Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • SuzuBell
    Member
    • Nov 2013
    • 22

    Pipeline for inferring tissues from liquid biopsy data

    In many cases, solid tissue biopsies cannot be performed in humans. If a liquid biopsy is performed on humans, we can assess microRNA, RNA, and DNA in the blood. These microRNA, RNA, and DNA presumably came from solid tissues. I have read that it can be inferred which tissues these microRNA, RNA, and DNA likely came from.

    If that is true, what is the general pipeline for such an analysis (at a high level, i.e. for a non expert)? Are there any resources for a newbie interested in this type of research to better understand this pipeline?
  • Michael.Ante
    Senior Member
    • Oct 2011
    • 127

    #2
    For solid tissue analysis, you have the assumption, that your observed xNA (miroRNA, RNA, DNA, etc.) is derived from one origin showing a certain 'fingerprint'. Meaning that your observation is depending on the tissue type. In such a case, you can use e.g. biogps.org datasets to perform a GSEA to obtain/rank the tissues which fit best to your data set.

    In your blood or other liquid sample, you have a mixture of xNAs produced in various tissues. The "simple" dependency assumption is not working.
    I fear it's not as easy to trace back from which tissue a certain amount a feature is produced. Especially, since you cannot deduce directly from an observed tissue-related expression/feature that this tissue is able to secrete the xNA into the blood.

    There might be certain microRNAs / RNAs which are only produced in certain tissue(s) exclusively (for instance MUP4 in mouse lacrimal glands).

    You might start with a simple likelihood model for each feature from which tissue it might came from.

    Best,

    Michael

    Comment

    • SuzuBell
      Member
      • Nov 2013
      • 22

      #3
      Thank you for your response. I can certainly write some scripts that use likelihood models to estimate which tissue each feature may be derived from.

      As a confirmation, it seems there are no software or published pipelines already available for inferring which tissues xNA from blood samples are likely derived from?

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
        The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
        Whether you're exploring Kheloyaar for the first time or want to understand...
        Today, 09:27 PM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        Today, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        Yesterday, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 10:04 AM
      0 responses
      8 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:08 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...